Moreover, in another study in a murine ovarian cancer model, dual antibody blockade or genetic knockout of LAG-3 and PD-1 resulted in enhanced CD8+ T-cell effector function and subsequent delayed tumor growth [92]. The gene discussed is CD8A; the disease is ovarian carcinoma.